China's healthcare spending has grown faster than GDP in recent decades. However, China still spends much less than other nations on healthcare per capita. China also lags in several health outcomes compared to other countries. The fee-for-service model in China may incentivize overspending. To improve its system, China could reform payments and invest more in public health prevention.
Central coordination for Financing UHC in Nigeria: Progress and Next StepsHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Francis Ukwuije. More: https://www.hfgproject.org/hcf-training-nigeria
Community based Health Insurance Scheme: An option to Health Care Financing i...Dr. Nkiru Nwamaka Ezeama
A synopsis of how community-based health insurance can ease the burden of health care financing in Nigeria.
Presented during the 2016 Physicians week of the Nigerian Medical Association
Central coordination for Financing UHC in Nigeria: Progress and Next StepsHFG Project
Presented during Day One of the 2016 Nigeria Health Care Financing Training Workshop. Presented by Dr. Francis Ukwuije. More: https://www.hfgproject.org/hcf-training-nigeria
Community based Health Insurance Scheme: An option to Health Care Financing i...Dr. Nkiru Nwamaka Ezeama
A synopsis of how community-based health insurance can ease the burden of health care financing in Nigeria.
Presented during the 2016 Physicians week of the Nigerian Medical Association
Pharmacoeconomics is a branch of health economics which compares the value of one drug or a drug therapy to another.
By understanding the principles, methods, and application of pharmacoeconomics, healthcare professionals will be prepared to make better decisions regarding the use of pharmaceutical products and services.
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
slideworld - Medical powerpoint search Enginerinki singh
Slideworld is a medical powerpoint search engine.Slideworld was founded by a team of international doctors to cater to the needs of the medical community looking for authoritative content in a concise format related to various medical topics.Search and share millions of medical powerpoint presentations.
Top 10 Global Future Trends 2015 - Roger James HamiltonRoger Hamilton
Slides from the Top 10 Trends 2014 Europe Tour, hosted in London, September 2014. How will the waves of the future impact your business? Join Roger James Hamilton in upcoming events and entrepreneur accelerators around the world at http://www.rogerjameshamilton.com
The role of primary care providers in occupational healthHealth and Labour
presentation by dr. Richard Roberts, president of the World Organisation of Family Doctors (Wonca) at the WHO/TNO/Dutchgovernment Congres 'Connecting Health and Labour' 29 - 1 December 2012
A presentation built by Clay Marsh, MD. executive director of the OSU Center for Personalized Medicine, designed to explain some of the scientific and social angles that are a part of personalized health care.
Pharmacoeconomics is a branch of health economics which compares the value of one drug or a drug therapy to another.
By understanding the principles, methods, and application of pharmacoeconomics, healthcare professionals will be prepared to make better decisions regarding the use of pharmaceutical products and services.
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
slideworld - Medical powerpoint search Enginerinki singh
Slideworld is a medical powerpoint search engine.Slideworld was founded by a team of international doctors to cater to the needs of the medical community looking for authoritative content in a concise format related to various medical topics.Search and share millions of medical powerpoint presentations.
Top 10 Global Future Trends 2015 - Roger James HamiltonRoger Hamilton
Slides from the Top 10 Trends 2014 Europe Tour, hosted in London, September 2014. How will the waves of the future impact your business? Join Roger James Hamilton in upcoming events and entrepreneur accelerators around the world at http://www.rogerjameshamilton.com
The role of primary care providers in occupational healthHealth and Labour
presentation by dr. Richard Roberts, president of the World Organisation of Family Doctors (Wonca) at the WHO/TNO/Dutchgovernment Congres 'Connecting Health and Labour' 29 - 1 December 2012
A presentation built by Clay Marsh, MD. executive director of the OSU Center for Personalized Medicine, designed to explain some of the scientific and social angles that are a part of personalized health care.
The Economics of Health Reform: Implications for Health ProfessionalsSage Growth Partners
Context and discussion regarding the problems, implications and solutions to health care reform with a contrarian point twist. Includes discussion of The Patient Protection and Affordable Care Act, economic data, insurance data, H.R. 3590, H.R. 4872, a history of health reform. Finally, the presentation outlines the implications for business, physicians and the health care system.
Biocat held a workshop entitled Fostering internationalization (II): China on 25 January 2013 in Barcelona, featuring Gao Ronghui, a life sciences consultant with extensive experience in technology transfer, fund raising and access to the Chinese market.
More information at: http://www.biocat.cat/en/news/biotechnology-internationalization-china
GRF One Health Summit 2012, Davos: Presentation by Adnan Ali Khan CHOUDHURY, Australian Centre for International and Tropical Health, School of Population Health, University of Queensland, Public Health Building , Herston Rd , Herston Qld 4006, Brisbane, Australia
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
4. Economic Resource Health
Demographics Allocation Statistics
• How Much Does • Where is Money • What is the
China Have? Spent/What Chinese
Does it Buy? Healthcare ROI?
8. Nurses and Hospital
Hospitals Physicians Midwives beds
China 13,119 1,862,630 1,259,240 30/10,000
US 5,010 793,648 2,927,000 31/10,000
World Health Organization 2009
9. % Total Health Expenditure (THE) on
Pharmaceuticals
Devel'd Nations
Pharma Other
15%
Total
Pharma 85%
Expenditure
as %GDP China
Pharma Other
40%
60%
Source: OECD, 2007 and China MoH, 2007
10. % Population Obese, 2009
Obese Adults in millions
200
100
18
2005 2010 2015 (est.)
30x
0% 10% 20% 30% 40%
OECD 2009 Health Data Report
12. Infant Mortality (Deaths per 1,000 Births), 2010
30.00
25.00
Sing (1)
20.00
Japan (4)
Germ (14)
15.00
Switz (15)
10.00
UK (31)
US (44)
5.00
China
(117)
0.00
2003 2004 2005 2006 2007 2008 2009 2010
Source: CIA World Factbook
13. Age
86
84.36
2009 Statistics
84
82.12
82
80.85
80 79.26 79.01
78.11
78
76
74 73.47
72
70
68
Macau (1) Japan (3) Switz (11) Germany (32) UK (36) US (48) China (N/A)
Countries (rank of 100 total)
Source: CIA World Factbook
15. • Take-home Message:
– China’s healthcare growth outpaces GDP growth
by almost 10% annually
– Fee-for-service incentives warp healthcare cost-
structure, driving individual spending
– China ranks very low in a number of health
statistics compared to other industrialized nations
– China would benefit from a change in fee-
structure, and investment in public health
Editor's Notes
-One of the lowest per capita healthcare expenditures in the world (rule of large numbers)-4 drivers of cost-inflation: 1) growing middle-class, 2) increased utilization by urbanization, 3) less exercise/higher fat diet, and 4) growing aging population ~100M in 10yrs
-Out-of-pocket individual composition has increased ~20% to ~60% over 24 year period-Gov’t contribution has decr’d from ~25% to ~19%-80% of Gov’t health expenditures go to urban areas, even though only 45% of the population lives in these areas-Currently about 9-10% of individual income allocated to healthcare; expected to grow to 16% by 2025
Transition: Resource Allocation-Despite China’s large population, aspects of its health-sector human capital and infrastructure are lacking in proportion-80% of Gov’t health expenditures go to urban areas, even though only 45% of the population lives in these areas
-Due to fee-for-service incentives for China’s physicians and hospitals, out-of-pocket costs on pharmaceuticals are close to 3x that of other developed nations-<10% of hospital income comes from Gov’t, the rest comes from fees-U.S. pharma expense as %GDP ~2.1%; T.H.E. ~13%
Transition: Health Statistics-20% of world’s obese people are Chinese-China’s obesity rate as a percent of population is about 7%, relatively low, but the rate of growth in obesity is climbing fast-The causes and correlations of obesity in China seem to be the opposite of many industrialized nations, where the poor are usually the most obese (e.g. the growing middle-class makes up the majority of growing obese in China)-Childhood obesity in China is also a major issue, as the rate has jumped 30-fold b/w 1985-2000-One-child policy leads to six pocket syndrome: 2 parents, and 4 grandparents lavishing food and amenities to 1 child
-Rising diabetes rates go hand-in-hand with the rising obesity rates-Approximately 3,000 new Type II diabetics are said to be diagnosed per day
-China’s infant mortality has consistently been ~10x higher than other developed nations, but it is trending downward-Very high infant mortality when compared to other industrialized nations (normalized for deaths <1 year-old/1000 births)-Clearly an area for China’s healthcare investment
-Comparative low LE, despite China’s healthy diet and culture of physical activity-Age increase has grown the slowest of developed countries, 2nd only to the US
-Become #1 killer since the ‘90s; Despite large population, cancer rates are not excessively high-One of highest in world in Stomach, Liver and Esophageal cancers-Breast cancer up 37% in last 10 years; estimated to reach 2.5M by 2021-Cancer rates expected to grow dramatically particularly in rural areas due to pollution, and in urban areas due to adoption of Western diet
-The data seems to point to the need to change China’s healthcare fee-structure/system-Nikki will now explain some of the prior changes in China’s system that brought the country to this point